Iron chelators inhibit VCAM-1 expression in human dermal microvascular endothelial cells

Journal of Investigative Dermatology

Volumn 120, Issue 5, 2003, Pages 871-879

  Koo, Sang Wahn ^a   Casper, Katherine A ^a   Otto, Kristen B ^a   Gira, Amy K ^a   Swerlick, Robert A ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Dermatology   (United States)

Author keywords

Adhesion; Endothelium; Gene regulation; Iron

Indexed keywords

DEFEROXAMINE; IRON CHELATE; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CELL ADHESION; DRUG EFFECT; ENDOTHELIUM CELL; GENETIC REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATORY CELL; MICROVASCULATURE; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; SKIN CELL; TISSUE INJURY;

EID: 0037960212     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2003.12144.x     Document Type: Article

References (44)

1. Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, Bosse DC, Lawley TJ: HMEC-1: Establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 99:683-690, 1992
2. Allen RG, Tresini M: Oxidative stress and gene regulation. Free Radic Biol Med 28:463-499, 2000
3. Baeuerle PA, Henkel T: Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 12:141-179, 1994
4. Bowie AG, Moynagh PN, O'Neill LA: Lipid peroxidation is involved in the activation of NF-kappaB by tumor necrosis factor but not interleukin-1 in the human endothelial cell line ECV304: Lack of involvement of H2O2 in NF-kappaB activation by either cytokine in both primary and transformed endothelial cells. J Biol Chem 272:25941-25950, 1997
5. Brenneisen P, Wenk J, Klotz LO, et al: Central role of Ferrous/Ferric iron in the ultraviolet B irradiation-mediated signaling pathway leading to increased interstitial collagenase (matrix-degrading metalloprotease (MMP)-1) and stromelysin-1 (MMP-3) mRNA levels in cultured human dermal fibroblasts. J Biol Chem 273:5279-5287, 1998
6. Das PK, de Boer OJ, Visser A, Verhagen CE, Bos JD, Pals ST: Differential expression of ICAM-1, E-selectin and VCAM-1 by endothelial cells in psoriasis and contact dermatitis. Acta Derm Venereol 186 (Suppl):21-22, 1994
7. Egan LJ, Mays PC, Huntoon CJ, et al: Inhibition of interleukin-1-stimulated NF-kappaB RelA/p65 phosphorylation by mesalamine is accompanied by decreased transcriptional activity. J Biol Chem 274:26448-26453, 1999
8. Elferink CJ, Reiners JJ Jr: Quantitative RT-PCR on CYP1A1 heterogeneous nuclear RNA: A surrogate for the in vitro transcription run-on assay. Biotechniques 20:470-477, 1996
9. Elices MJ, Osborn L, Takada Y, Crouse C, Luhowskyj S, Hemler ME, Lobb RR: VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 60:577-584, 1990
10. Gille J, Paxton LL, Lawley TJ, Caughman SW, Swerlick RA: Retinoic acid inhibits the regulated expression of vascular cell adhesion molecule-1 by cultured dermal microvascular endothelial cells. J Clin Invest 99:492-500, 1997
11. Gille J, Swerlick RA, Lawley TJ, Caughman SW: Differential regulation of vascular cell adhesion molecule-1 gene transcription by tumor necrosis factor alpha and interleukin-1 alpha in dermal microvascular endothelial cells. Blood 87:211-217, 1996
12. Groves RW, Ross EL, Barker JN, MacDonald DM: Vascular cell adhesion molecule-1: Expression in normal and diseased skin and regulation in vivo by interferon gamma. J Am Acad Dermatol 29:67-72, 1993
13. Iademarco MF, MeQuillan JJ, Rosen GD, Dean DC: Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J Biol Chem 267:16323-16329, 1992
14. Ivan M, et al: HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: Implications for O2 sensing. Science 292:464-468, 2001
15. Kim JS, Lee S, Lee T, Lee YW, Trepel JB: Transcriptional activation of p21 (WAF1/CIP1) by apicidin, a novel histone deacetylase inhibitor. Biochem Biophys Res Commun 281:866-871, 2001
16. Kramer JL, Baltathakis I, Alcantara OS, Boldt DH: Differentiation of functional dendritic cells and macrophages from human peripheral blood monocyte precursors is dependent on expression of p21 (WAF1/CIP1) and requires iron. Br J Haematol 117:727-734, 2002
17. Lechleitner S, Gille J, Johnson DR, Petzelbauer P: Interferon enhances tumor necrosis factor-induced vascular cell adhesion molecule 1 (CD106) expression in human endothelial cells by an interferon-related factor 1-dependent pathway. J Exp Med 187:2023-2030, 1998
18. Lin M, Rippe RA, Niemela O, Brittenham G, Tsukamoto H: Role of iron in NF-kappa B activation and cytokine gene expression by rat hepatic macrophages. Am J Physiol 272:G1355-G1364, 1997
19. Litchfield TM, Smith CH, Atkinson BA, Norris PG, Elliott P, Haskard DO, Lee TH: Eosinophil infiltration into human skin is antigen-dependent in the late-phase reaction. Br J Dermatol 134:997-1004, 1996
20. Lontz W, Sirsjo A, Liu W, Lindberg M, Rollman O, Torma H: Increased mRNA expression of manganese superoxide dismutase in psoriasis skin lesions and in cultured human keratinocytes exposed to IL-1 beta and TNF-alpha. Free Radic Biol Med 18:349-355, 1995
21. Marui N, Offermann MK, Swerlick R, et al: Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest 92:1866-74, 1993
22. McCord JM: Iron, free radicals, and oxidative injury. Semin Hematol 35:5-12, 1998
23. Neish AS, Read MA, Thanos D, Pine R, Maniatis T, Collins T: Endothelial interferon regulatory factor 1 cooperates with NF-kappa B as a transcriptional activator of vascular cell adhesion molecule 1. Mol Cell Biol 15:2338-2569, 1995
24. Norris P, Poston RN, Thomas DS, Thornhill M, Hawk J, Haskard DO: The expression of endothelial leukocyte adhesion molecule-1 (ELAM-1), intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in experimental cutaneous inflammation: A comparison of ultraviolet B erythema and delayed hypersensitivity. J Invest Dermatol 96:763-770, 1991
25. Norton J, Sloane JP, al-Saffar N, Haskard DO: Vessel associated adhesion molecules in normal skin and acute graft-versus-host disease. J Clin Pathol 44:586-591, 1991
26. Onuma S: Immunohistochemical studies of infiltrating cells in early and chronic lesions of psoriasis. J Dermatol 21:223-232, 1994
27. Paxton LL, Li LJ, Secor V, Duff JL, Naik SM, Shibagaki N, Caughman SW: Flanking sequences for the human intercellular adhesion molecule-1 NF-kappaB response element are necessary for tumor necrosis factor alpha-induced gene expression. J Biol Chem 272:15928-15935, 1997
28. Pourzand C, Watkin RD, Brown JE, Tyrrell RM: Ultraviolet A radiation induces immediate release of iron in human primary skin fibroblasts: The role of ferritin. Proc Natl Acad Sci USA 96:6751-6756, 1999
29. Rosen GM, Rauckman EJ: Spin trapping of superoxide and hydroxyl radicals. Meth Enzymol 105:198-209, 1984
30. Saccani S, Pantano S, Natoli G: p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment. Nat Immunol 3:69-75, 2002
31. Saccani S, Pantano S, Natoli G: Two waves of nuclear factor kappa B: Recruitment to target promoters. J Exp Med 193:1351-1359, 2001
32. Sakurai H, Chiba H, Miyoshi H, Sugita T, Toriumi W: 1kappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain. J Biol Chem 274:30353-30356, 1999
33. Saran M, Bors W: Radical reactions in vivo: An overview. Radiat Environ Biophys 29:249-262, 1990
34. Schreck R, Rieber P, Baeuerle PA: Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. Embo J 10:2247-2258, 1991
35. Sharkey P, Ecdy DJ, Burrows D, McCaigue MD, Bell AL: A possible role for superoxide production in the pathogenesis of contact dermatitis. Acta Derm Venereol 71:156-159, 1991
36. Silber A, Newman W, Reimann KA, Hendricks E, Walsh D, Ringler DJ: Kinetic expression of endothelial adhesion molecules and relationship to leukocyte recruitment in two cutaneous models of inflammation. Lab Invest 70:163-175, 1994
37. Swerlick RA, Lee KH, Li LJ, Sepp NT, Caughman SW, Lawley TJ: Regulation of vascular cell adhesion molecule 1 on human dermal microvascular endothelial cells. J Immunol 149:698-705, 1992b
38. Swerlick RA, Lee KH, Wick TM, Lawley TJ: Human dermal microvascular endothelial but not human umbilical vein endothelial cells express CD36 in vivo and in vitro. J Immunol 148:78-83, 1992a
39. Voest EE, van Faassen E, Marx JJ: An electron paramagnetic resonance study of the antioxidant properties of the nitroxide free radical TEMPO. Free Radic Biol Med 15:589-595, 1993
40. Wakita H, Sakamoto T, Tokura Y, Takigawa M: E-selectin and vascular cell adhesion molecule-1 as critical adhesion molecules for infiltration of T lymphocytes and eosinophils in atopic dermatitis. J Cutan Pathol 21:33-39, 1994
41. Wang D, Baldwin AS Jr: Activation of nuclear factor-kappaB-dependent transcription by tumor necrosis factor-alpha is mediated through phosphorylation of RelA/p65 on serine 529. J Biol Chem 273:29411-29416, 1998
42. Wang GL, Semenza GL: Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: Implications for models of hypoxia signal transduction. Blood 82:3610-3615, 1993
43. Wang D, Westerheide SD, Hanson JL, Baldwin AS Jr: Tumor necrosis factor alpha-induced phosphorylation of RelA/p65 on Ser529 is controlled by casein kinase II. J Biol Chem 275:32592-32597, 2000
44. Woetmann A, Nielsen M, Christensen ST, et al: Inhibition of protein phosphatase 2A induces serine/threonine phosphorylation, subcellular redistribution, and functional inhibition of STAT3. Proc Natl Acad Sci USA 96:10620-10625, 1999